Home / Companies / Seres Therapeutics, Inc. / 4 Apr 2024
Seres Therapeutics, Inc.: meeting of 4 Apr 2024
Votes reported on Form N-PX, item by item
163 Form N-PX filers reported votes at the Seres Therapeutics, Inc. meeting of 4 Apr 2024. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 54.9% of reported votes for; 33 filers withheld from or voted against at least one nominee.
204 vote records from 58 filers. 27 of the 58 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
225 vote records from 161 filers. 20 of the 153 filers that marked the item either way voted against management. 8 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
102 vote records from 58 filers. 3 of the 58 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
102 vote records from 58 filers. 0 of the 58 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
102 vote records from 58 filers. 6 of the 58 filers that marked the item either way voted against management.
CORPORATE GOVERNANCESecurity holder
A stockholder proposal on Simple Majority Vote
91 vote records from 53 filers. 53 of the 53 filers that marked the item either way voted against management.
Several categoriesSecurity holder
Shareholder proposals (not separable from the filings)
Filers described these proposals in wordings that could not be matched to one another, so they are shown together.
10 vote records from 4 filers. 4 of the 4 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor | 6. Proposal |
|---|---|---|---|---|
| Vanguard | For | For | For | For * |
| BlackRock and iShares | For | For | For | No report |
| Fidelity | Abstain or withhold * | Against * | For | For * |
| Dimensional | No report | Against * | No report | No report |
| State Street and SPDR | Split or no vote | For | For | For * |
| Invesco | For | For | For | For * |
| Equitable | Abstain or withhold * | For | For | For * |
| Charles Schwab | For | For | For | For * |
| ProShares and ProFunds | Abstain or withhold * | For | For | For * |
| John Hancock and Manulife | Abstain or withhold * | For | For | For * |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | Against * | Against * | For * |
| J.P. Morgan | No report | For | No report | No report |
| Goldman Sachs | No report | For | No report | No report |
| PGIM and Prudential | No report | For | No report | No report |
| Northern Trust and FlexShares | Split or no vote | For | For | For * |
| SEI | For | For | For | For * |
| T. Rowe Price | For | For | For | For * |
| Lincoln Financial | Split or no vote | For | For | For * |
| Voya | For | For | For | For * |
| Nationwide | Abstain or withhold * | For | For | For * |
| Victory Capital | Abstain or withhold * | For | For | For * |
| Guggenheim and Rydex | Abstain or withhold * | For | For | For * |
| BNY Mellon | No report | For | No report | No report |
| Principal | Abstain or withhold * | For | For | For * |
| Pacific Life funds | For | For | For | For * |
| Global X | For | For | For | No report |
| Federated Hermes | No report | For | No report | No report |
| AllianceBernstein | No report | For | No report | No report |
| DWS | Abstain or withhold * | For | For | For * |
| Janus Henderson | No report | For | No report | No report |
| Neuberger Berman | No report | For | No report | No report |
| Natixis and Loomis Sayles | No report | For | No report | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Seres Therapeutics, Inc. meeting?
163 Form N-PX filers reported votes at the meeting of 4 Apr 2024. On say-on-pay, 20 of 153 voted against management (13.1%). One proposal from security holders could be told apart in the filings. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Seres Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Seres Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Seres Therapeutics, Inc. with a meeting date within three days of 4 Apr 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.